Drug
Rop
Rop: highest development phase Post-Market, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| ROP NCT00485069 | Post-Market | Parkinson Disease |
Latest
No recent events.
Follow Rop on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.